Post My Press Release

Free Press Release Distribution

Category: Hardware (Page 1 of 2)

Epoxy Resin Market Size is projected to reach 8.77 Billion USD By 2021

The Global Epoxy Resin Market size is projected to reach USD 8.77 Billion by 2021 from the estimated USD 6.31 Billion in 2015, registering a CAGR of 5.77% between 2016 and 2021. The key drivers of the market are increasing penetration of composites, emerging demand from developing countries, and revolutionary advancements in weight reduction and safety.

Request for PDF report: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=762

Paints & coatings is the biggest application segment for the epoxy resin market

The paints & coatings segment is the largest application and is projected to remain the same in the overall epoxy resin market, in terms of volume, during the forecast period. Economic expansion in the developing countries of Asia-Pacific will increase the demand of epoxy resin for paints & coatings application in building & construction and automotive end-use industries.

Building & construction sector expected to be the dominant end-use industry for epoxy resin

Increase in employment, increase in public & private non-residential spending, and rise of green building construction are driving the epoxy resin market in the building & construction end-use industry. Though the growth of this sector has slowed down, it would still provide opportunities for the growth of the epoxy resin market.

Asia-Pacific estimated to be the largest market during forecast period

Asia-Pacific is the largest market for epoxy resin, both in terms of volume and value, followed by North America and Western Europe. China, the U.S., and Germany are the largest producers of epoxy resins the respective regions. Building & construction is the largest consumer of epoxy resins materials in Asia-Pacific. China and Japan have the largest shares of the Asia-Pacific epoxy resin market. The market in India is witnessing the highest growth rate.

Major manufacturers operational in Epoxy Resin Market are Olin Corporation (U.S.), Nan Ya Plastics Corporation (Taiwan), Huntsman Corporation (U.S.), Hexion Inc. (U.S.), Kukdo Chemical Co. Ltd. (South Korea), Chang Chung Plastics Co. Ltd. (Taiwan), Aditya Birla Chemicals (Thailand), the 3M Company (U.S.), BASF SE (Germany), and Sinopec Corporation (China Olin Corporation (U.S.).

Early buyers will receive 10% customization on this report.

Don’t miss out on business opportunities in Epoxy Resin Market.

For more details read our blog: https://chemabd007.blogspot.com/2019/03/epoxy-resin-market-expected-to-grow-at.html

About MarketsandMarkets

MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC. 
630 Dundee Road 
Suite 430 
Northbrook, IL 60062 
USA: 1-888-600-6441 
sales@marketsandmarkets.com

Talc Market worth 4.01 Billion USD by 2027 at a CAGR of 4.6%

The report “Talc Market by Deposit Type (Talc Carbonate, Talc Chlorite), End-Use Industry (Plastics, Pulp & Paper, Ceramics, Paints & Coatings, Cosmetics & Personal Care, Pharmaceuticals, Food), and Region (Europe, APAC, North America) – Global Forecast to 2027”, is projected to grow from USD 2.68 billion in 2018 to USD 4.01 billion by 2027, at a CAGR of 4.6% from 2018 to 2027. Increasing demand for talc from the automotive industry, rapid industrialization, increased disposable incomes of the middle-class populations of emerging economies, and increasing R&D activities for the development of new grades of talc are opportunities for the growth of the talc market.

Request for free Sample pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=6281259

Browse 135 market data Tables and 28 Figures spread through 143 Pages and in-depth TOC on “Talc Market

Based on deposit type, the talc carbonate segment is estimated to account for the largest share of the talc market in 2018

Based on deposit type, the talc carbonate segment is estimated to account for the largest share of the talc market in 2018. Talc carbonate deposits are mainly composed of talc carbonate and traces of chlorite. Carbonate is primarily composed of magnesite (magnesium carbonate) or dolomite (magnesium and calcium carbonate).

Based on end-use industry, the plastics segment is estimated to be the largest segment of the talc market in 2018

Based on end-use industry, the plastics segment is estimated to be the largest segment of the talc market in 2018. Talc is used as a reinforcing filler in polypropylene and engineering thermoplastics for automotive parts, domestic applications, electrical & electronic components, and food packaging.

The talc market in the Asia Pacific is expected to witness the highest growth during the forecast period

Asia Pacific is the fastest-growing region for talc globally. The growth of the Asia Pacific talc market can be attributed to the increasing demand for talc-reinforced polypropylene from the automotive industry. Continuously increasing population and rapid industrialization are factors driving the growth of the Asia Pacific talc market. China is the largest consumer of talc in the Asia Pacific region.

Key players in the talc market include Imerys (France), Mondo Minerals (Netherlands), Minerals Technologies (US), IMI Fabi (Italy), Golcha Minerals (India), and Nippon Talc (Japan), among others.

Early buyers will receive 10% free customization on this report.

Don’t miss out on business opportunities in Talc Market.

Speak to Our Analyst and gain crucial industry insights that will help your business grow.

https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=6281259

About MarketsandMarkets

MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC. 
630 Dundee Road 
Suite 430 
Northbrook, IL 60062 
USA : 1-888-600-6441 
sales@marketsandmarkets.com

Caps & Closures Market expected to be worth 68.71 Billion USD by 2021, at a CAGR of 5.62%, from 2016–2021

[199 Pages report] MarketsandMarkets projects that the Caps & Closures Market size will grow from USD 49.78 Billion in 2015 to USD 68.71 Billion by 2021, at an estimated CAGR of 5.62%. The caps & closures market is expected to witness high growth as a result of the growing end-use industry such as beverage and healthcare as well as the rising concerns toward product quality and safety. Caps & closures seal the content within the container and allows appropriate dispense of the contents.

Request for free sample report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=1314

Table of Contents

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Caps & Closures Market, By Raw Material

7 Caps & Closures Market, By Type

8 Caps & Closures Market, By End-Use Industry

9 Caps & Closures Market, By Region

10 Competitive Landscape

11 Company Profiles

12 Appendix

The market share of plastic is the largest as per raw material and is further projected to be the fastest-growing segment. This is closely followed by metal which has the second-highest growth rate. Plastic resin such as polypropylene (PP) and polyethylene (PE) are widely used with PP expected to be the fastest-growing subsegment. The other types of raw materials that are used for manufacturing caps & closures include wood, glass, paperboard, and rubber & elastomer.

Factors such as stringent regulations in the caps & closures industry as well as growing demand for the substitutes such as blister packs act as a restraint for the growth of the market. The global market for caps & closures is dominated by players such as RPC Group PLC (U.K.), Crown Holdings Incorporation (U.S.), Amcor Limited Plc (Australia), Rexam PLC (U.K.), Berry Plastics Corporation (U.S.), Silgan Holdings Inc. (U.S.), AptarGroup Incorporated (U.S.), and Guala Closures Group (Italy). These players adopted various strategies such as expansion, agreements, acquisitions, and new product developments to cater to the needs of the caps & closures market.

Early buyers will receive 10% customization on this report.

Don’t miss out on business opportunities in Caps & Closures Market.

Read Our blog for more details: http://bit.ly/2DlIYqB

About MarketsandMarkets

MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC. 
630 Dundee Road 
Suite 430 
Northbrook, IL 60062 
USA: 1-888-600-6441 
sales@marketsandmarkets.com

Global FAM20B Gene(XYLK Antibody) Market Projected to Deliver Greater Revenues during the Forecast Period until 2025

The following research report is a compilation of high-end data that has been researched thoroughly to highlight the various trends prevailing across the FAM20B Gene(XYLK Antibody) market. This study is titled “Global FAM20B Gene(XYLK Antibody) Market Insights, Forecast to 2025”, which carefully examines several vital factors such as market share, market revenue, market dynamics and competitive scenario active in the target market for the period between 2019 and 2025.

Request for free Sample @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=1908008

This report studies the global market size of FAM20B Gene(XYLK Antibody) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of FAM20B Gene(XYLK Antibody) in these regions.

This research report categorizes the global FAM20B Gene(XYLK Antibody) market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

In 2017, the global FAM20B Gene(XYLK Antibody) market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the FAM20B Gene(XYLK Antibody) market based on company, product type, application and key regions.

The various contributors involved in the value chain of FAM20B Gene(XYLK Antibody) include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the FAM20B Gene(XYLK Antibody) include
Abbexa Ltd(UK)
Novus Biologicals(US)
Biobyt(UK)
Atlas Antibodies(SE)

Market Size Split by Type
Above 90%
Above 95%
Above 99%
Others
Market Size Split by Application
Biopharmaceutical Companies
Hospitals
Bioscience Research Institutions
Others

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

In this study, the years considered to estimate the market size of FAM20B Gene(XYLK Antibody) are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of FAM20B Gene(XYLK Antibody) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

Browse Full Report with TOC@  https://www.marketresearchhub.com/report/global-fam20b-genexylk-antibody-market-insights-forecast-to-2025-report.html

Table of Contents

1 Study Coverage
1.1 FAM20B Gene(XYLK Antibody) Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global FAM20B Gene(XYLK Antibody) Market Size Growth Rate by Type
1.4.2 Above 90%
1.4.3 Above 95%
1.4.4 Above 99%
1.4.5 Others
1.5 Market by Application
1.5.1 Global FAM20B Gene(XYLK Antibody) Market Size Growth Rate by Application
1.5.2 Biopharmaceutical Companies
1.5.3 Hospitals
1.5.4 Bioscience Research Institutions
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global FAM20B Gene(XYLK Antibody) Market Size
2.1.1 Global FAM20B Gene(XYLK Antibody) Revenue 2016-2025
2.1.2 Global FAM20B Gene(XYLK Antibody) Sales 2016-2025
2.2 FAM20B Gene(XYLK Antibody) Growth Rate by Regions
2.2.1 Global FAM20B Gene(XYLK Antibody) Sales by Regions
2.2.2 Global FAM20B Gene(XYLK Antibody) Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 FAM20B Gene(XYLK Antibody) Sales by Manufacturers
3.1.1 FAM20B Gene(XYLK Antibody) Sales by Manufacturers
3.1.2 FAM20B Gene(XYLK Antibody) Sales Market Share by Manufacturers
3.1.3 Global FAM20B Gene(XYLK Antibody) Market Concentration Ratio (CR5 and HHI)
3.2 FAM20B Gene(XYLK Antibody) Revenue by Manufacturers
3.2.1 FAM20B Gene(XYLK Antibody) Revenue by Manufacturers (2016-2018)
3.2.2 FAM20B Gene(XYLK Antibody) Revenue Share by Manufacturers (2016-2018)
3.3 FAM20B Gene(XYLK Antibody) Price by Manufacturers
3.4 FAM20B Gene(XYLK Antibody) Manufacturing Base Distribution, Product Types
3.4.1 FAM20B Gene(XYLK Antibody) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers FAM20B Gene(XYLK Antibody) Product Category
3.4.3 Date of International Manufacturers Enter into FAM20B Gene(XYLK Antibody) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

Continue…@@$

Enquire about this Report –  https://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1908008    

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of pharma market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Us

90 State Street,
Albany, NY 12207,
United States
Toll Free : 800-998-4852 (US-Canada)
Email : press@marketresearchhub.com
Website : https://www.marketresearchhub.com/
Read Industry News at – https://www.industrynewsanalysis.com/

Digital Utility Market Value to reach $244.31 Billion by 2022

According to the new market research report Digital Utility Market by Network (Generation, Transmission and Distribution, and Retail), Technology (Hardware and Integrated Solutions (Cloud and Software, Services)), and Region (North America, Europe, and Asia-Pacific) – Global Forecast to 2022″, published by MarketsandMarkets™, Global digital utility market is projected to grow at a CAGR of 12.57%, from 2017 to 2022, to reach a market size of USD 244.31 billion by 2022. North American market held the largest share in 2016 followed by the markets in Europe and Asia-Pacific. However, by 2022, the market in Asia-Pacific is projected to gain the largest share. Digital utility market growth is driven by strict regulatory requirements for electric utilities, energy efficiency mandates demanding carbon emission reduction, and increase in the number of distributed and renewable power generation projects.

Don’t miss out on business opportunities in Digital Utility Market. Speak to Analyst and gain crucial industry insights that will help your business grow:

https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=230978516

The digital utility market in Asia-Pacific is projected to grow at the fastest rate during the forecast period. Increasing investment in the electrical infrastructure and growing decentralized power generation will be driving the growth of the digital utility market in the region during the forecast period. The developing smart grid projects and investments in smart cities are also driving the digital utility market in Asia-Pacific.

Browse and in-depth TOC on “Digital Utility Market

63 – Tables

35 – Figures

144 – Pages

View more detailed TOC @

https://www.marketsandmarkets.com/Market-Reports/digital-utility-market-230978516.html

The growth of the transmission and distribution segment is primarily driven by aging infrastructure in the power utilities industry. New digital devices and communications and control systems improve the efficiency of assets and increase the ability of operators to monitor and manage electric transmission and distribution systems. This would ultimately create new revenue pockets for the digital utility market during the forecast period.

North America: The largest market for digital utility

The market in North America is currently the largest market for digital utility, closely followed by the European market. Rising investments in aging electrical infrastructure and increasing electricity demand are driving the digital utility market in the North America. The market in the U.S. is estimated to be the largest in the region, followed by the markets in Canada and Mexico, during the forecast period.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=230978516   

The leading players in the digital utility market includes Accenture plc (Ireland), Cap Gemini S.A. (France), Cognizant Technology Solutions Corporation (U.S.), General Electric Company (U.S.), Siemens AG (Germany), SAP SE (Germany), International Business Machines Corporation (U.S.), and Oracle Corporation (U.S.), among others.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.


Contact:

Mr. Shelly Singh

MarketsandMarkets™ INC.
630 Dundee Road

Suite 430

Northbrook, IL 60062

USA : 1-888-600-6441

Email: sales@marketsandmarkets.com

Radiation-Induced Myelosuppression Treatment Market By 2028 Region, Application, Driver, Trends & Forecasts

radiation induced myelosuppression treatment market

Rapidly improving healthcare infrastructure and reimbursement scenario has been a major booster for the healthcare industry in developing regional markets. With incessantly increasing number of cancer cases, it is more likely that the subsequent demand for a wide range of treatments adopted to treat cancer patients would also remain on a constant rise over the course of coming years.

Radiation therapy has been a significant part of cancer treatment and the consistently high success rate associated with radiotherapy is projected to further push demand for radiation-induced myelosuppression treatment worldwide.

A new market research study on global radiation-induced myelosuppression treatment forecasts steady growth for the market in the next few years. Future Market Insights projects a moderate, just-under 4% yearly growth outlook, in 2019 and ahead.

Nutropenia is foreseen to generate maximum demand for radiation-induced myelosuppression treatment, whereas injectables are identified to hold a substantial share in the total market value, based on the route of administration of radiation-induced myelosuppression treatment. Thrombocytopenia and anemia are likely to present lucrative opporunities for radiation-induced myelosuppression treatment providers.

Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-8116 

Report tracks key factors driving revenue growth of the market –

  • Increasing prevalence of cancers
  • Early diagnosis, promising improved chances of positive outcomes
  • Fostering R&D funds supporting cancer research
  • Strong product pipeline
  • Bolstering adoption of chemo-radiotherapy in cancer treatment

In the backdrop of patent expiry, a majority of market leaders are shifting their focus to the expansion of product pipeline of a wide range of innovative formulations, likely to shape the radiation-induced myelosuppression treatment landscape.

  • Myelo001 by Myelo Therapeutics GmbH recently received an FDA approval as an orphan drug to be used in the ARS (acute radiation syndrome) treatment.
  • Mylan NV and Pfizer Inc. also reveived FDA approvals for their recently launched biosimilars – Epogen and Neupogen, and Neulasta respectively.

Patent expiry of originator biologics formulations is creating investment opportunities in biosimilars production – for the operators in radiation-induced myelosuppression treatment landscape. As there is a considerable cost difference of around 20% between originator biologics and biosimilars, patients are inclined more towards an economical means of treatment, thereby fueling the scope of penetration of radiation-induced myelosuppression treatment in coming years.

Backed by a majority of established players housing strong bases across North America, especially the US, the report indicates a steady growth outlook for the radiation-induced myelosuppression treatment market in the region. North America will reportedly continue to account for over 65% share in the global market value.

New product launches currently mark the top developmental strategy adopted by leading companies competing in the radiation-induced myelosuppression treatment market. A majority of key players are also identified to focus on enhancing their geographical foothold in global radiation-induced myelosuppression treatment landscape.  The report in a distinct section covers some of the key competitors operating in radiation-induced myelosuppression treatment marketplace, emphasizing their financial as well as strategic profiles in depth.

Request to View TOC @ https://www.futuremarketinsights.com/askus/rep-gb-8116

A few of the profiled companies include Pfizer Inc., Janssen Pharmaceutical NV, Janssen Global Services, LLC (Johnson & Johnson), Amgen Inc., Mylan NV, Teva Pharmaceutical Industries Ltd., Novartis AG, and Partner Therapeutics, Inc.

In the highly consolidated competitive landscape of global radiation-induced myelosuppression treatment, the three top ranking companies, i.e. Janssen Pharmaceutical NV, Amgen Inc., and Teva Pharmaceutical Industries Ltd. dominate in terms of market value. These players continue to hold winning revenue shares in the radiation-induced myelosuppression treatment owing to strong global presence and a considerable number of new drug approvals. Established companies are entering strategic partnerships and collaborations with regional leaders, in an effort to achieve better penetration into regional markets.

Population Health Management Solution Market To Be At Forefront By 2026

Coherent Market Insights added Latest Research Report titled ” Population Health Management Solution Market, by Component (Software and Services), by Medium (Web Based Medium, and Cloud Based Medium), by End User (Hospitals, Ambulatory Care Provider, Insurance Provider, and Others), and by Region – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026 ” to its Large Report database.

Population health management solution aggregates all the data from different healthcare platform (Diagnostics, Pharmacy, and Billing Department in healthcare facility) related to the patient. The data is analyzed and presented in comprehensive actionable form to healthcare providers for efficient clinical outcome and save overall healthcare cost. Population healthcare management tracks individuals amongst vast group of patients by applying business intelligence tools to different set of data and create single document, which is easy to analyze and clinical decision can be taken over same by each member across the healthcare ecosystem.

Population healthcare management provides various advantages. It improves quality of healthcare due to comprehensive picture provided by collection of multiple data points on one platform with better tracking of patient. Pharmaceutical healthcare management solutions saves unnecessary healthcare cost. Also, it allows better clinical management in case of chronic disease using information technology based approaches. Healthcare management allows the healthcare provider to fill the healthcare gap i.e. lack of coordinated effort amongst stakeholder in health care, lack of effective patient monitoring etc.

This is gap can be filled by promoting real time data access and monitoring. This can be done by monitoring diagnostic data, prescription data, billing data and other health care data, which can be assessed and addressed in case of care gap. For healthcare insurer, population healthcare management allows the value-based reimbursement rather than simple payment transfer and helps in business decision making process. Overall PHM promotes better health for population and reduces hospital admissions.

Market Dynamics

Population healthcare management market is projected to witness upward growth during the forecast period due to increasing prevalence of chronic disease worldwide. Chronic disease such as cancer, cardiovascular disease, diabetes, asthma (chronic lung disease) account for the major healthcare burden annually. According to World Health Organization data in 2017, around 40 million people die each year due to chronic disease, which accounts for 70% of all deaths globally. Cardiovascular diseases is responsible for 17.7 million death annually, followed by cancers (8.8 million deaths), respiratory diseases (3.9million deaths), and diabetes (1.6 million deaths).

Population healthcare management solutions provides better clinical management of this disease. Increasing number of geriatric population worldwide is expected to further propel growth of population healthcare management solutions.

Competitive Landscape

Some of the key players operating in the population health management solution market include Allscripts, Inc., Cerner Corporation, Conifer Health Solutions, Healthagen, LLC, OptumHealth, Epic Corporation, Inc., Philips Wellcentive, eClinicalWorks, Health Catalyst, LLC, IBM Corporation, i2i Population Health, Verscend Technologies, Inc., Caradigm, and Care Evolution.

Ask For Sample Copy Of This Business Research Report : https://www.coherentmarketinsights.com/insight/request-sample/1732

Market Taxonomy

On the basis of component, the global population health management solution market is segmented into:

  • Software
  • Services

On the basis of medium, the global population health management solution market is segmented into:

  • Web based medium
  • Cloud based medium

On the basis of end user, the global population health management solution market is segmented into:

  • Hospitals
  • Insurance provider
  • Ambulatory care provider
  • Others

Regional Insights

Reducing number of uninsured people would also benefit the market. According to U.S. Census Bureau data, in 2016, an estimated 8.8 percent or 28.1 million people were without health insurance coverage, which is lower than 2015, in which 9.1 percent or 29.0 million people were uninsured. Europe is projected to be second lucrative market due to high number of old age population. According to Europa Statistics in 2017, around 19% of current Europe population is more than 60 in age, which would rise to 25% in near future.

Asia Pacific region provides potential opportunity for growth of the population health management solution market, owing to highest number of deaths caused due to chronic disease. More than 12 million and around 80% worldwide chronic disease death are reported from this region according to World Health Organization (WHO) factsheet in 2017. Healthcare infrastructure in this region is slowly improving, which would also promote use of population health management solution.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

Spinal Stenosis Market Industry Outlook, Size, Share, Growth Prospects, Key Opportunities, Trends and Forecasts 2016-2026

Spinal stenosis is narrowing of the spinal column and mainly occurs from a combination of aging and degenerative changes in the spine. This puts pressure on the spinal cord and the spinal nerve roots, and may cause pain, numbness, or weakness in the legs. Spinal stenosis mostly affects people above 60 years of age but can also occur in younger people born with the abnormal spinal canal. Lumbar spinal stenosis, cervical spinal stenosis and thoracic spinal stenosis are the three main types of spinal stenosis. About 75% of the cases of spinal stenosis occurs in the lower lumbar region.

The primary symptoms associated with spinal stenosis are radiculopathy and myelopathy. Myelopathy is of greater concern as pressure on the spinal cord can lead to permanent spinal cord damage.  Diagnosis of spinal stenosis involves the complete evaluation of spine. The most common diagnostic test for spinal stenosis are MRI scan and X-ray. In some cases CT scan can be conducted in order to diagnose the condition. Spinal stenosis treatment can be conservative or surgical depending upon the severity of the disease.

Spinal Stenosis Market: Drivers and Restraints

Increasing prevalence of degenerative spondylolisthesis and degenerative scoliosis among rapidly ageing population, rising number of obese population suffering from spine deformities, and rising demand for minimally invasive spine surgery procedures are the key factors fueling the growth of the global spinal stenosis market. However, high cost of treatment procedure, stringent product approval process and unclear reimbursement policies are the prime factors expected to hamper the global spinal stenosis market growth.

Spinal Stenosis Market: Segmentation

The global spinal stenosis market is segmented based on product type, treatment type end user and region.

Based on Product Type

  • Thoracic Fusion and Lumbar Fusion Devices
    • Anterior Thoracic and Lumbar Fusion Devices
    • Posterior Thoracic and Lumbar Fusion Devices
    • Interbody Thoracic and Lumbar Fusion Devices
  • Cervical Fusion Devices
    • Anterior Cervical Fusion Devices
    • Posterior Cervical Fusion Devices

Request Sample Report @  https://www.futuremarketinsights.com/reports/sample/rep-gb-1388 

Based on treatment type

  • Surgical treatment
    • Discectomy
    • Laminectomy
    • Foraminotomy
    • Facetectomy
    • Corpectomy
  • Non-Surgical Treatment

Based on end user type

  • Hospitals
  • Ambulatory Surgical centers
  • Rehabilitation Centers

Spinal Stenosis Market: MarketOverview

Numerous prescription medications are available to cure spinal stenosis. Epidural steroid injections and anti-inflammatory medications may be used to in case of acute spinal stenosis. Such nonsurgical treatments offer ways to control symptoms and enable you to improve without surgery. Whereas patients with chronic spinal stenosis opt for surgical procedures such as laminectomy, corpectomy foraminotomy and others.  Due to rapidly ageing population and increasing prevalence of osteoarthritis, rheumatoid arthritis and spondylolisthesisare expected fuel the market value of global Spinal Stenosis market over the forecasted period.

Spinal Stenosis Market: Region-wise Overlook

Geographically, North America is expected to dominate the global spinal stenosis market followed by Europe owing to increase in number of aging population. This increase in the base of geriatric population is expected to result in rising prevalence of spinal disorders such as herniated discs and osteoarthritis. In addition, ready availability of skilled healthcare professionals would significantly lead to increase in number of surgical procedures thereby driver the growth of spinal stenosis market during the forecast period. However, lack of adequate physician and patient awareness/education about newly developed treatment procedures and technologies and high pricing pressure on market players are other factors hampering market growth. Asia-Pacific is expected to exhibit strongest growth dynamics in spinal stenosis market due to rising economic affluence in various parts of this region.

Request to View TOC @  https://www.futuremarketinsights.com/toc/rep-gb-1388

Spinal Stenosis Market: Key Players 

Key companies operational in global spinal stenosis market are Medtronic Inc., DePuy Synthes, Stryker Corporation, Orthofix International N.V., NuVasive, Inc., Zimmer Biomet Holdings, Inc., Globus Medical, Inc., Alphatec Holdings, Inc., K2M Group Holdings, Inc., and LDR Holding Corporation.

Page 1 of 2

Powered by WordPress & Theme by Anders Norén